Humans

Cumulative non-HDL cholesterol links to cardiovascular risk

Each 100-unit increase in cumulative non-HDL cholesterol carried an adjusted hazard ratio of 1.07 for incident cardiovascular disease over nine years.

Journal of Diabetes and Metabolic Disorders4 Oct 2026, 09:00 BST

In a nationwide study of 5,283 adults from the China Health and Retirement Longitudinal Study, researchers examined how cumulative non-high-density lipoprotein cholesterol (non-HDL-C) exposure influences cardiovascular-kidney-metabolic syndrome progression. Participants had repeated lipid measurements in 2011 and 2015 and entered the study at stages 0 to 3. Over a median follow-up of 9.0 years, 948 participants developed incident clinical cardiovascular disease, representing stage 4. Higher cumulative non-HDL-C exposure was independently associated with cardiovascular disease risk, with an adjusted hazard ratio of 1.07 per 100-unit increase (95% CI, 1.02–1.12). The relationship was stronger in earlier stages, with hazard ratios of 1.18 in stage 0 and 1.17 in stage 1, compared to 1.03 in stage 2 and 1.03 in stage 3.

Why it matters

Cardiovascular-kidney-metabolic syndrome captures interconnected organ decline that accelerates with age. Showing that atherogenic lipid accumulation drives risk primarily in earlier stages highlights the importance of timely intervention before cardiometabolic damage compounds.

Caveats

Because this study is observational, it cannot establish a causal link between cumulative lipid exposure and disease progression. The findings are also derived entirely from a single Chinese cohort and may not generalize across all populations.